Healthcare >> CEO Interviews >> February 4, 2002
JAMES C. O'SHEA has served as Chairman and Chief Executive Officer of
Bioject Medical Technologies, Inc. since March 1995. Prior to joining
Bioject, he was President and Chief Operating Officer of Biopure
Corporation, a developer of oxygen therapeutics. Prior to 1989, Mr.
O'Shea was Executive Vice President of Marketing and Scientific Affairs
at Delmed Inc., a manufacturer of peritoneal dialysis solutions and
parenteral products. He is a member of the Board of Directors of PSC,
Inc., a leading worldwide supplier of scanning and data collection
systems located in Portland, Oregon. Profile
Mr. O'Shea: Bioject is a leader in the emerging field of needle-free
drug injections. There are three distinct market opportunities
